Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data ; volume:20 ; number:1 ; day:31 ; month:7 ; year:2021 ; pages:1-15 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (31.7.2021), 1-15, 12.2021
- Creator
-
Khunti, Kamlesh
Kosiborod, Mikhail N.
Kim, Dae Jung
Kohsaka, Shun
Lam, Carolyn S. P.
Goh, Su-Yen
Chiang, Chern-En
Shaw, Jonathan E.
Cavender, Matthew A.
Tangri, Navdeep
Franch-Nadal, Josep
Holl, Reinhard W.
Jørgensen, Marit E.
Norhammar, Anna
Eriksson, Johan G.
Zaccardi, Francesco
Karasik, Avraham
Magliano, Dianna J.
Thuresson, Marcus
Chen, Hungta
Wittbrodt, Eric
Bodegård, Johan
Surmont, Filip
Fenici, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01345-z
- URN
-
urn:nbn:de:101:1-2021102821001819412915
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2023, 12:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khunti, Kamlesh
- Kosiborod, Mikhail N.
- Kim, Dae Jung
- Kohsaka, Shun
- Lam, Carolyn S. P.
- Goh, Su-Yen
- Chiang, Chern-En
- Shaw, Jonathan E.
- Cavender, Matthew A.
- Tangri, Navdeep
- Franch-Nadal, Josep
- Holl, Reinhard W.
- Jørgensen, Marit E.
- Norhammar, Anna
- Eriksson, Johan G.
- Zaccardi, Francesco
- Karasik, Avraham
- Magliano, Dianna J.
- Thuresson, Marcus
- Chen, Hungta
- Wittbrodt, Eric
- Bodegård, Johan
- Surmont, Filip
- Fenici, Peter
- SpringerLink (Online service)
Other Objects (12)
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions : state of the art
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
Sodium-glucose cotransporter 2 inhibitors in cardiology: Slow start and sweet passage
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions : state of the art
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
Sodium-glucose cotransporter 2 inhibitors in cardiology: Slow start and sweet passage
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions : state of the art
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
Sodium-glucose cotransporter 2 inhibitors in cardiology: Slow start and sweet passage
High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review